-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732.P1.33 732. Clinical Allogeneic Transplantation: Results: Poster I

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Anemias, Biological, HSCs, Leukemia, survivorship, bone marrow, CML, Diseases, Non-Biological, Bone Marrow Failure, CMML, Combinations, Elderly, Therapies, chemotherapy, Genetic Disorders, MDS, Pediatric, cell expansion, Immune Disorders, Technology and Procedures, Young Adult, Cell Lineage, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, transplantation, TKI, stem cells
Saturday, December 5, 2020: 7:00 AM-3:30 PM

Ephraim J. Fuchs, MD, MBA1, Shannon R McCurdy, MD2*, Scott R. Solomon, MD3, Tao Wang, PhD4*, Michelle Kuxhausen, MS5*, Yvette L Kasamon, MD1*, Monzr M. Al Malki, MD6, Shahinaz Gadalla, MD, PhD7*, Sophie Paczesny, MD, PhD8, Steven GE Marsh, BSc, PhD, ARCS9*, Bronwen E. Shaw, PhD, MRCP, FRCPath10, Stephen R. Spellman, MS11*, Stephanie J. Lee, MD, MPH11,12 and Effie Petersdorf, MD13*

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
3Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA
4Medical College of Wisconsin, Milwaukee, WI
5Center for International Blood and Marrow Transplant Research, Minneapolis, MN
6Department of Hematology and Hematopoietic cell transplantation, City of Hope National Medical Center, Duarte, CA
7Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, MD
8Indiana University School of Medicine, Indianapolis, IN
9Anthony Nolan Research Institute & University College London Cancer Institute, Royal Free Campus, London, United Kingdom
10CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
11CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
12Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
13Fred Hutchinson Cancer Research Center, Seattle, WA

Gérard Socié, MD, PhD1*, Dietger Niederwieser, MD, PhD2, Nikolas Von Bubnoff3*, Mohamad Mohty, MD, PhD4, Jeffrey Szer, MBBS5, Reuven Or, MD6*, Jason P Butler, MBBS, MMedSc, FRACP, FRCPA7, Eva Maria Wagner, MD8, Edouard Forcade, MD, PhD9*, Jaime Sanz Caballer, MD, PhD10*, Domenico Russo, MD11, Giovanni Grillo, MD12*, Tsila Zuckerman, MD13, Sinem Civriz Bozdag, MD14*, David Ritchie, MD, ChB, PhD, FRACP, FRCPA15*, Shalini Chaturvedi16*, Anirudh Prahallad, PhD17*, Karen Sinclair, PhD17*, Celine Wilke, MD17* and Robert Zeiser, MD18

1Assistance Publique Hôpitaux des Paris, Hématologie-Transplantation, Paris France and INSERM Unité Mixte de Recherche 976, Hôpital St. Louis, Université de Paris, Paris, France
2Department of Hematology and Oncology, University Leipzig, Leipzig, Germany
3Department of Haematology and Oncology, University Hospital Schleswig-Holstein, Lübeck, Germany
4Hôpital Saint-Antoine, Sorbonne University, INSERM UMRs 938, Paris, France
5Department of Clinical Haematology, Royal Melbourne Hospital, Melbourne, VIC, Australia
6Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Jerusalem, Israel
7Bone Marrow Transplant Unit, Royal Brisbane and Women's Hospital, Brisbane, Australia
8Department of Hematology, Oncology, and Pneumology, University Medical Center Mainz, Mainz, Germany
9CHU Bordeaux, Hospital Haut-Leveque, Pessac, FRA
10Hospital La Fe, Valencia, Spain
11Unit of Blood Diseases and Bone Marrow Transplantation, Department of Clinical and Experimental Sciences, ASST-Spedali Civili, University of Brescia, Brescia, Italy
12Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy, Italy
13Hematology Institute and Bone Marrow Transplantation, CRIR institute, Rambam Health Care Campus, Haifa, Israel
14Faculty of Medicine, Department of Hematology, Ankara University, Ankara, Turkey
15Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
16Novartis Pharmaceuticals Corporation, East Hanover, NJ
17Novartis Pharma AG, Basel, Switzerland
18Department of Medicine I Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany

Hemant S. Murthy, MD1, Kwang Woo Ahn, PhD2,3*, Noel Estrada-Merly, MS4*, Lohith Gowda, MD5, Bhagirathbhai Dholaria, MBBS6, Susan Bal, MD, MBBS7, Hassan B. Alkhateeb, MD8*, Deepa Jagadeesh, MD, MPH9, Betul Oran, MD, MS10, Ryotaro Nakamura, M.D.11, Bart L. Scott, MD12, Craig S. Sauter, MD13, Francine M. Foss, MD14, Mohamed A kharfan-Dabaja, MD, MBA15 and Wael Saber, MD, MS16

1Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
2Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
3Department of Medicine, CIBMTR (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin, Milwaukee, WI
4CIBMTR (Center for International Blood and Marrow Transplant Research) Medical College of Wisconsin, Milwaukee, WI
5Hematology, Yale University School of Medicine, New Haven, CT
6Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical center, Nashville, TN
7O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
8Division of Hematology, Mayo Clinic, Rochester, MN
9Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Solon, OH
10Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
12Fred Hutchinson Cancer Center, Seattle, WA
13Memorial Sloan Kettering Cancer Center, New York, NY
14Hematology, Yale Cancer Center, New Haven, CT
15Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
16CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Ivan S. Moiseev1*, Julia J. Vlasova1*, Elena V. Morozova1*, Anastasiya Beynarovich2*, Evgeniya Borzenkova1*, Anna Dotcenko2*, Olga Kudyasheva, MD2*, Varvara Nikolaevna Ovechkina2*, Olga Vladislavovna Pirogova, MD, PhD2*, Valentina Vladimirovna Porunova, MD2*, Tatiana Rudakova2*, Olesya Smykova2*, Axel R. Zander3 and Sergey N. Bondarenko1*

1RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
2RM Gorbacheva Research Institute, Pavlov University, Saint-Petersburg, Russian Federation
3University of Hamburg, Hamburg, Germany

Madlen Jentzsch, MD1*, Dominic Brauer1*, Juliane Grimm, MD1*, Marius Bill, MD, PhD1*, Donata Backhaus, MD1*, Julia Schulz1*, Dietger Niederweiser, MD1*, Uwe Platzbecker, MD2 and Sebastian Schwind, MD1*

1Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
2Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany

Elena V. Morozova1*, Julia J. Vlasova1*, Maria V. Barabanshikova1*, Axel R. Zander2,3, Ksenia Jurovskaya4*, Tatyana L. Gindina4*, Ildar Barhatov5*, Sergey N. Bondarenko1*, Ivan S. Moiseev1*, Ludmila S Zubarovskaya, MD, PhD, professor6* and Aleksandr D. Kulagin, MD, PhD1*

1RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
2Raisa Gorbacheva Memorial Institute of Children Oncology Hematology and Transplantation, First Pavlov State Medical University, Sant-Petersburg, Russian Federation
3Huntsman Cancer Institute, University of Utah, Salt Lake City
4RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia, Saint-Petersburg, Russian Federation
5Raisa Gorbacheva Memorial Scientific Institute of Children Oncology, Hematology and Transplantation, First Pavlov State Medical University of Saint-Petersburg, Saint-Petersburg, RUS
6R.M.Gorbacheva Memorial Institute of Oncology, Hematology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation

Lars Klingen Gjærde, MD1*, Sisse Rye Ostrowski, MD, PhD, DMSc, Ass Prof2*, Niels Smedegaard Andersen, MD, PhD, DMSc1*, Lone Smidstrup Friis, MD, PhD1*, Brian Kornblit, MD, PhD1*, Søren Lykke Petersen, MD, DMSc1*, Ida Schjødt, MD, PhD1* and Henrik Sengeløv, MD, DMSc, Prof1*

1Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
2Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Alexander Joseph Ambinder, MD, MPH1, Matthew L Smith2*, Ravi Varadhan, PhD3*, Amy E. DeZern, MD3, Mark Levis, MD, PhD3, Gabriel Ghiaur, MD, PhD4, Richard J. Jones, MD3 and B. Douglas Smith, MD5

1Johns Hopkins Hospital, Baltimore, MD
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, MD
3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
4Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
5Johns Hopkins Medical Institutes, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Vanessa E Kennedy, MD1, Gavin Hui, MD2*, Daria Gaut, MD3, Varun Mittal, MD4, Caspian Oliai, M.D.5, Lori Muffly, MD, MS6, Aaron C. Logan, MD, PhD, MPhil7 and Gabriel N. Mannis, MD8

1University of California- San Francisco, San Francisco, CA
2Department of Medicine, Stanford University, Stanford, CA
3Department of Medicine, Univeristy of California Los Angeles, Los Angeles, CA
4Division of Malignant Hematology/BMT, university of California San francisco, San francisco, CA
5University of California, Los Angeles, Los Angeles, CA
6Assistant Professor of Medicine, Stanford University School of Medicine, Stanford, CA
7Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
8Division of Hematology, Department of Medicine, Stanford University, Stanford, CA

Eun-Ji Choi, MD, PhD1, Je-Hwan Lee, MD, PhD2, Jun-Hong Park, MD1*, Han-Seung Park, MD1*, Jung-Hee Lee, MD, PhD1*, Youngshin Lee1*, Young-Ah Kang1*, Mijin Jeon1*, Ji Min Woo1*, Hyeran Kang3* and Kyoo Hyung Lee, MD, PhD1*

1Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
2Department of Hematology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea, Republic of (South)
3Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea, Republic of (South)

Jan Philipp Bewersdorf, MD1, Martin S. Tallman, MD 2,3, Christina Cho, MD4,5, Amer M. Zeidan, MBBS, MHS6,7 and Maximilian Stahl, MD8

1Department of Internal Medicine, Yale University, New Haven, CT
2Memorial Sloan-Kettering Cancer Center, New York, NY
3Weill Cornell Medical College, New York, NY
4Department of Medicine, Weill Cornell Medical College, New York, NY
5Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center,, Yale University, New Haven, CT
7Yale University School of Medicine and Yale Cancer Center, New Haven, CT
8Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Samia Harbi1*, jean Marie Boher2*, Edouard Forcade, MD3, Patrice Chevallier, MD, PhD4, Peffault De Latour Régis5*, Florent Malard, MD, PhD6*, Sylvie Francois, MD7*, Amandine Charbonnier, MD8*, Eric Hermet, MD9*, Claude-Eric Bulabois, MD10*, Anne Huynh11*, Ana Berceanu, MD12*, Thomas Cluzeau, MD, PhD13, Marie Thérèse Rubio, MD, PhD14*, Sabine Furst1*, Mohamad Mohty, MD, PhD15, Raynier Devillier16,17* and Didier Blaise, MD1

1Institut Paoli Calmettes, Marseille, France
2institut paoli calmettes, marseille, France
3Service d’hematologie et thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
4Hematology Clinic, CHU Nantes, Nantes, France
5hopital saint louis, paris, France
6Saint Antoine Hospital, PARIS, France
7Clinical Hematology, Angers University Hospital, Angers, France
8Hematology department, CHU Amiens, Amiens, France
9Unit of adult cell therapy and clinical hematology, University hospital of Clermont-Ferrand, Clermont-Ferrand, France
10Department of Hematology, CHU Grenoble, Service d'hématologie Clinique, Grenoble, France
11CHU Toulouse, Toulouse, France
12Clinical Hematology, Besançon University Hospital, Besançon, France
13CHU De Nice, Nice, France
14CHRU Nancy, Hôpital Brabois, Vandœuvre-les Nancy, France
15Saint Antoine Hospital, Paris, France
16CRCM / INSERM U1068, Marseille, France
17Aix Marseille University, Medicine Faculty, Marseille, France

Muhned Alhumaid, MD1,2, Georgina S. Daher-Reyes, MD3*, Arjun Law, MD1*, Auro Viswabandya, MD1, Armin Gerbitz, MD1*, Fotios Michelis, MD, PhD1*, Igor Nicolas Novitzky-Basso, MD, PhD, MRCP, FRCPath1, Jeffrey H. Lipton, MD, PhD1, Jonas Mattson, MD, PhD1*, Ivan Pasic, MD, PhD1*, Rajat Kumar, MD1, Wilson Lam, MD1, Zeyad Al-Shaibani, MD1, Hassan Sibai, MBBS4* and Dennis Dong Hwan Kim, MD1

1Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
2King Saud Medical City, Riyadh, Saudi Arabia
3Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Leukemia Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Mohamed Samour, MD1, Georg Aue, MD, PhD1, Joseph Clara2*, Jennifer Wilder3*, Robert Reger, MS1*, Rosa Nadal Rios, MD1*, Kate Stringaris, MD, PhD1*, Brian Wells1*, Lisa Cook1*, Kristen Gunn1*, Reem A Shalabi, PharmD1*, Josef Rivero1*, Patricia Prince1*, David F. Stroncek, MD4, Willy A. Flegel, MD5, Xin Tian, PhD6* and Richard W. Childs, MD1*

1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2National Heart, Lung, and Blood Institute, National Heart, Lung and Blood Institute, Bethesda, MD
3National Cancer Institute, National Institutes of Health, Bethesda, MD
4Center for Cellular Engineering, National Institutes of Health, Bethesda, MD
5Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD
6Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Naonori Harada1*, Hiroshi Okamura, MD, PhD2*, Takahiko Nakane, MD, PhD3*, Shiro Koh, MD, PhD4*, Satoru Nanno, MD, PhD3*, Mitsutaka Nishimoto, MD, PhD5*, Asao Hirose, MD, PhD3*, Mika Nakamae, MD, PhD3*, Yasuhiro Nakashima, MD, PhD3*, Hideo Koh, MD, PhD3*, Masayuki Hino, MD, PhD3 and Hirohisa Nakamae, MD, PhD3*

1Department of Hematology, Osaka City University Graduate School of Medicine, Osaka-City, Japan
2Hematology, Graduate School of Medicine, Osaka City University, Osaka, OSA, Japan
3Hematology, Graduate School of Medicine, Osaka City University, Osaka, Japan
4Graduate School of Medicine, Osaka City University, Osaka, Japan
5Department of Hematology, Osaka City University Graduate School of Medicine, Osaka, Japan

Hanzhou Qi1*, Hua Jin2* and Qifa Liu, MD1

1Department of Hematology, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

Theodoros Karantanos, MD, PhD1, Hua-Ling Tsai, ScM2*, Lukasz P. Gondek, MD, PhD3, Mark Levis, MD, PhD4, Margaret M. Showel, MD5*, Amy E. DeZern, MD4, Ivana Gojo, MD4, Ravi Varadhan, PhD4*, Richard J. Jones, MD4 and Tania Jain, MD5

1Hematology/Medical Oncology, Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
2Oncology Biostatistics and Bioinformatics, Johns Hopkins University, Baltimore, MD
3Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD

Kyoko Fuse, MD, Ph.D1*, Masayoshi Masuko, MD, Ph.D2, Shohei Mizuno, MD, PhD3*, Kaito Harada, MD4*, Naoyuki Uchida, MD, PhD5, Noriko Doki, MD, PhD6*, Takahiro Fukuda7*, Masatsugu Tanaka, MD8*, Yukiyasu Ozawa, MD, PhD9*, Kazuhiro Ikegame, MD, PhD10*, Tetsuya Eto, MD, PhD11*, Yoshinobu Kanda, MD, PhD12, Tatsuo Ichinohe13, Yoshiko Atsuta, MD, PhD14* and Masamitsu Yanada, MD, PhD15*

1Division of Transplantation Medicine, Niigata University Faculty of Medicine, Niigata City, Japan
2Division of Transplantation Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan
3Department of Hematology, Aichi Medical University School of Medicine, Nagakute, AIC, Japan
4Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan
5Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Tokyo, Japan
6Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
7Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
8Department of Hematology, Kanagawa Cancer Center, Yokohama, KAN, Japan
9Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
10Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
11Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan
12Jichi Medical Univ., Saitama, Japan
13Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
14Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
15Aichi Cancer Center, Nagoya, Japan

Joseph Maakaron, MD1*, Karen Chen, MS2*, Mei-Jie Zhang, PhD3*, Christopher S. Hourigan, MD, DPhil4, Mark Litzow, MD5, Wael Saber, MD, MS6, Partow Kebriaei, MD7 and Daniel J. Weisdorf, MD8

1Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
2CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
3Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Laboratory of Myeloid Malignancies, Hematology Branch, NHLBI, Bethesda, MD
5Division of Hematology, Mayo Clinic, Rochester, MN
6CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
7Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

Hemalatha G Rangarajan, MD1, Joseph R Stanek, MS2*, Hisham Abdel-Azim, MD3*, Arunkumar Modi, MBBS, MPH4*, Ann Haight, MD5, Christopher M McKinney, MD6, Daniel J McKeone, MD7*, David K. Buchbinder, MD, MSHS8, Emmanuel Katsanis, MD9, Ghada A Abusin, MBBS10*, Ibrahim Ahmed, MD11, Jason Law, MD12*, Jorge Galvez Silva, MD13*, Kanwaldeep K Mallhi, MD14*, Lauri S Burroughs, MD14*, Peter J Shaw, MD15*, Robert Greiner, MD7*, Shalini Shenoy, MD16, Michael A Pulsipher, MD17 and Rolla Abu-Arja, MD18*

1Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Childrens Hospital, Columbus, OH
2Division of Biostatistics, Nationwide Children's Hospital, Columbus, OH
3Section of Transplantation and Cellular Therapy, Children’s Hospital Los Angeles Cancer and Blood Disease Institute, Los Angeles, CA
4Pediatric Stem Cell Transplant and Cellular Therapy, University of Iowa Stead Family Children’s Hospital, Iowa City, IA
5Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Emory University, Atlanta, GA
6Center for Cancer and Blood Disorders, Department of Pediatrics, Children’s Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, CO
7Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Penn State Health Children’s Hospital, Hershey, PA
8Division of Pediatrics Hematology, Oncology, Blood and Marrow Transplant, Children’s Hospital of Orange County, Orange, CA
9Departments of Pediatrics, University of Arizona, Tucson, AZ
10University of Michigan, Ann Arbor, MI
11Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Children's Mercy Hospital, Kansas City, MO
12Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Floating Hospital for Children, Tufts Medical Center, Boston, MA
13Division of Pediatric Blood and Bone Marrow Transplantation, Nicklaus Children's Hospital, Miami, FL
14Clinical Research Division, Fred Hutchinson Cancer Research Center and the Department of Pediatrics, University of Washington School of Medicine, Seattle, WA
15The Children's Hospital at Westmead, Sydney, AUS
16Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO
17Children’s Hospital Los Angeles Cancer and Blood Disease Institute, Los Angeles, CA
18Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital, Columbus, OH

Mohammed Essa1,2,3*, Enas Basher2*, Rodaina Abujoub2* and Abdulrahman Alsultan, MD4

1King Saud Bin Abdulaziz University For Health Sciences, Riyadh, Saudi Arabia
2Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Riyadh, Saudi Arabia
3King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
4Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia

*signifies non-member of ASH